This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
BP (BP.L) - BP does not plan to increase annual investments this decade but still expects to bring nine new projects online in 2017 as it focuses on improving efficiency, Chief Executive Bob Dudley said in an interview on Wednesday. Closing price 417.50p (Reuters)
GlaxoSmithKline (GSK.L) - GlaxoSmithKline's experimental vaccination to prevent the intensely painful condition known as shingles remained 90% effective in people over age 70 even four years after receiving the injection, according to data published on Wednesday. Closing Price 1613.50p. (Reuters)
Morrison’s (MRW.L) - Britain's No. 4 supermarket reported a rise in first-half profit for the first time in four years and a third straight quarter of underlying sales growth, indicating its recovery is gaining momentum. Closing price 193.60p (Reuters)
Next (NXT.L) – Reported -1.5% fall in first half profit and stated trading since July has been challenging and volatile. Closing price 5210.00p (Reuters)
Redrow PLC (RDW.L) – Redrow directors are proposing a buy-back of up to 37 million shares of the company at the 2016 AGM. Closing Price 390.00p. (Reuters)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research